Registration will open at 9am and refreshments will be available.
| Time | Title | Speaker | Affiliation | |
| Session 1: Chair - Dr Frank Blaney, GSK | ||||
| 9.50 - 10.00 | Opening Remarks | Dr Darren Flower | Jenner Institute | |
| 10.00 - 10.50 |
Plenary Lecture: Computational Drug Discovery.
|
Prof Graham Richards | University of Oxford | |
| 10.50 - 11.20 | Secret Diary of a Modeller: Confessions from Beyond the Cutting Edge. | Dr Christopher Woods | University of Bristol | |
| 11.20 - 11.50 | The changing face of the kinase ATP site: new binding modes and evolutionary library design. | Dr Dave Sheppard | Biofocus DPI | |
| 11.50 - 12.20 | Understanding biological and chemical space using data visualisation tools and techniques | Dr Trevor Howe | Johnson and Johnson | |
| 12.20 - 13.30 | LUNCH and Exhibition | |||
| Session 2: Chair - Dr Christine Richardson, Biofocus DPI | ||||
| 13.30 - 14.00 | Case studies and experiences from fragment based drug design. | Dr Chris Murray | Astex Therapeutics | |
| 14.00 - 14.30 | Structure-based design of protein kinase inhibitors. | Dr Paul Bamborough | GSK | |
| 14.30 - 15.00 | Experiences with docking studies: successes and challenges. | Dr Nicolas Foloppe | Vernalis | |
| 15.00 - 15.30 | Refreshments | |||
| Session 3: Chair - Dr Steve Maginn, CCG | ||||
| 15.30 - 16.00 | Integration of computational and predictive ADMET into Drug Design. | Dr Mark Cronin | Liverpool John Moores University | |
| 16.00 - 16.30 | Title to be confirmed. | Dr Andy Davis | AstraZeneca | |
| 16.30 - 16.35 | Closing Remarks | |||